Last updated on January 2020

An Investigational Immuno-therapy Study to Investigate the Safety and Effectiveness of Nivolumab and Nivolumab Combination Therapy in Virus-associated Tumors


Brief description of study

The purpose of this study to investigate the safety and effectiveness of nivolumab, and nivolumab combination therapy, to treat patients who have virus-associated tumors. Certain viruses have been known to play a role in tumor formation and growth. This study will investigate the effects of the study drugs, in patients who have the following types of

tumors
  • Anal canal cancer-No longer enrolling this tumor type
  • Cervical cancer
  • Epstein Barr Virus (EBV) positive gastric cancer-No longer enrolling this tumor type
  • Merkel Cell Cancer
  • Penile cancer-No longer enrolling this tumor type
  • Vaginal and vulvar cancer-No longer enrolling this tumor type
  • Nasopharyngeal Cancer - No longer enrolling this tumor type
  • Head and Neck Cancer - No longer enrolling this tumor type

Clinical Study Identifier: NCT02488759

Find a site near you

Start Over

Winship Cancer Institute

Atlanta, GA United States
  Connect »

Local Institution

New Orleans, LA United States
  Connect »

Levine Cancer Institute

Charlotte, NC United States
  Connect »

Stephenson Cancer Center

Oklahoma City, OK United States
  Connect »

UPMC Eye and Ear Institute

Pittsburgh, PA United States
  Connect »

Sanford Clinic Clinical Research

Sioux Falls, SD United States
  Connect »

Local Institution

Capital Federal, Argentina
  Connect »

Local Institution

Marseille Cedex 9, France
  Connect »

Local Institution

Heidelberg, Germany
  Connect »

Local Institution

Oaxaca de Juarez, Mexico
  Connect »

Local Institution

Amsterdam, Netherlands
  Connect »

Local Institution

Utrecht, Netherlands
  Connect »

Local Institution

Birmingham, United Kingdom
  Connect »

Local Institution

Glasgow, United Kingdom
  Connect »

Local Institution

London, United Kingdom
  Connect »

Beth Israel Desc. Med Ctr

Boston, MA United States
  Connect »

Local Institution

Seoul, Korea, Republic of
  Connect »

Institut Claudius Regaud

Toulouse Cedex 9, France
  Connect »